Search

Your search keyword '"Lloyd, Krissey E."' showing total 26 results

Search Constraints

Start Over You searched for: Author "Lloyd, Krissey E." Remove constraint Author: "Lloyd, Krissey E."
26 results on '"Lloyd, Krissey E."'

Search Results

1. Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies

2. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains

3. HIV-1 VACCINES: Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

4. Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved

5. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

6. Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

7. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

8. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity

9. Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies

10. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

11. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses

12. Induction of Antibodies with Long Variable Heavy Third Complementarity Determining Regions by Repetitive Boosting with AIDSVAX® B/E in RV144 Vaccinees

13. Immunoglobulin Gene Insertions and Deletions in the Affinity Maturation of HIV-1 Broadly Reactive Neutralizing Antibodies

14. HIV-1 Envelope gp41 Antibodies Can Originate from Terminal Ileum B Cells that Share Cross-Reactivity with Commensal Bacteria

15. Toll-Like Receptor 7/8 (TLR7/8) and TLR9 Agonists Cooperate To Enhance HIV-1 Envelope Antibody Responses in Rhesus Macaques

16. Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

17. Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion

18. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.

20. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains.

21. WRP/srGAP3 Facilitates the Initiation of Spine Development by an Inverse F-BAR Domain, and Its Loss Impairs Long-Term Memory.

22. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses

23. Immunoglobulin Gene Insertions and Deletions in the Affinity Maturation of HIV-1 Broadly Reactive Neutralizing Antibodies

24. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8

25. Induction of Antibodies with Long Variable Heavy Third Complementarity Determining Regions by Repetitive Boosting with AIDSVAX® B/E in RV144 Vaccinees.

26. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.

Catalog

Books, media, physical & digital resources